Igor Matushansky, MD, PhD

Medical Oncology
Cancer Care
More specialties
Accepting New Patients
Virtual Visits/Telehealth
Profile Headshot

Profile Navigation

Overview

For over 20 years Dr. Matushansky’s clinical practice has focused exclusively on the treatment and care of patients with sarcomas (i.e., cancers of musculoskeletal origins) and/or sarcoma related diseases.

Dr. Matushansky earned a BA degree from Columbia College, Columbia University and MD & PhD degrees from Albert Einstein College of Medicine. He performed his internal medicine residency at New York Presbyterian Hospital/Weill Cornell Medical Center and then completed a fellowship in Medical Oncology, as well as a post-doctoral research fellowship in Cancer Biology at Memorial Sloan Kettering Cancer Center.

Areas of Expertise / Conditions Treated

  • Ewing's Sarcoma
  • Mesothelioma
  • Sarcoma
  • Soft Tissue Sarcoma
  • Solid Tumors

Academic Appointments

  • Assistant Professor of Medicine at CUMC

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center

Gender

  • Male

Schedule an Appointment

Virtual Visits/Telehealth

Virtual Visits allow you to connect with your provider from the comfort, convenience, and safety of your own home.

Schedule Virtual Visit

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In

Location(s)

CUIMC/Herbert Irving Pavilion
161 Fort Washington Avenue
New York, NY 10032
Phone:
212-305-5098
Open location in Google Maps

Insurance Accepted

Aetna

  • Aetna Signature Administrators
  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Student Health

Affinity Health Plan

  • Essential Plan
  • Medicaid Managed Care

Amida Care

  • Special Needs

Cigna

  • EPO
  • Great West (National)
  • HMO
  • Medicare Managed Care
  • POS
  • PPO

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross/Blue Shield

  • EPO
  • HMO
  • Medicare Managed Care
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199
  • NYP Employee Plan

MagnaCare (National)

  • MagnaCare

Medicare

  • Railroad
  • Traditional Medicare

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

RiverSpring

  • Special Needs

UnitedHealthcare

  • Compass (Exchange)
  • Empire Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • Oxford Freedom
  • Oxford HMO
  • Oxford Liberty
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth
  • Special Needs

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

World Trade Center Health Plan

  • World Trade Center Health Plan

*Before your appointment, please contact the doctor’s office or your insurance provider to verify that your insurance is accepted. This list of insurances can change, and the insurance plans listed may not be accepted at all office locations for this provider.

Credentials & Experience

Education & Training

  • Albert Einstein College of Medicine of Yeshiva University
  • Internship: NewYork-Presbyterian Hospital/Weill Cornell Medical Center
  • Residency: NewYork-Presbyterian Hospital/Weill Cornell Medical Center
  • Fellowship: Memorial Sloan-Kettering Cancer Center, NY

Board Certifications

  • Internal Medicine
  • Medical Oncology

Research

Selected Publications

Chemotherapy use in elderly patients with soft tissue sarcoma: a population-based study.

Matushansky I, Dela Cruz F, Insel BJ, Hershman DL, Neugut AI.

Cancer Invest. 2013 Feb;31(2):83-91. doi: 10.3109/07357907.2012.756112. Epub 2013 Jan 15.

PMID: 23320812

PPARγ agonists enhance ET-743-induced adipogenic differentiation in a transgenic mouse model of myxoid round cell liposarcoma.

Charytonowicz E, Terry M, Coakley K, Telis L, Remotti F, Cordon-Cardo C, Taub RN, Matushansky I.

J Clin Invest. 2012 Mar;122(3):886-98. doi: 10.1172/JCI60015. Epub 2012 Feb 1.

PMID: 22293175

Adjuvant chemotherapy in 2011 for patients with soft-tissue sarcoma.

Matushansky I, Taub RN.

Nat Rev Clin Oncol. 2011 Mar 22;8(7):434-8. doi: 10.1038/nrclinonc.2011.36.

PMID: 21423256

MFH classification: differentiating undifferentiated pleomorphic sarcoma in the 21st Century.

Matushansky I, Charytonowicz E, Mills J, Siddiqi S, Hricik T, Cordon-Cardo C.

Expert Rev Anticancer Ther. 2009 Aug;9(8):1135-44. doi: 10.1586/era.09.76.

PMID: 19671033

Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway.

Matushansky I, Hernando E, Socci ND, Mills JE, Matos TA, Edgar MA, Singer S, Maki RG, Cordon-Cardo C.

J Clin Invest. 2007 Nov;117(11):3248-57. doi: 10.1172/JCI31377.

PMID: 17948129

Mechanisms of sarcomagenesis.

Matushansky I, Maki RG.

Hematol Oncol Clin North Am. 2005 Jun;19(3):427-49, v. doi: 10.1016/j.hoc.2005.03.006.

PMID: 15939190